US 10189846
Hepatitis B antiviral agents
granted A61KA61K31/519A61K45/06
Quick answer
US patent 10189846 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/519, A61K45/06, A61P, A61P31/20